P121. Comparisons of Long-term Outcomes after Mechanical Mitral Replacement: Asian Versus Western Populations

Jae Woong Choi Poster Presenter
Seoul National University Hospital
Seoul
South Korea
 - Contact Me

Academic Record

2001 - 2003       Premedical School, Seoul National University

2003 - 2007       College of Medicine, Seoul National University

2011 - 2018       Graduate School, Seoul National University (received Ph.D.)

Training Record

2007 - 2008          Internship, Seoul National University Hospital

2008 – 2012          Residency, Thoracic and Cardiovascular Surgery

Seoul National University Hospital

Work experience

2012 -2015           Military service in Korean Army as the rank of Captain (army surgeon)

2015 – 2016          Clinical fellow, Seoul National University Hospital

2016 -2017           Clinical professor, Seoul National University Hospital

2018 - 2019           Assistant professor, Seoul National University Hospital

2019 -               Assistant professor, Seoul National University and Seoul National University Hospital

2023.9 -             Research fellow, Duek University Medical Center

Monday, May 4, 2026: 9:00 AM - 4:00 PM
McCormick Place Lakeside Center  
Room: Exhibit Hall, Poster Area 

Description

Objective: Although the recommended target INR for anticoagulation therapy after mitral valve replacement (MVR) does not vary by race, current guidelines are largely based on studies conducted in Western population. However, studies have suggested that the optimal level of anticoagulation may differ between Asian and Western populations. This study aimed to compare long-term outcomes after mechanical MVR between Asian and Western populations.
Methods: From 2000 to 2020, 980 consecutive patients undergoing mechanical MVR were enrolled at two tertiary centers located in Asia and West, respectively. Propensity scores were calculated using 22 preoperative and operative variables, and 1:1 propensity score matching was performed to compare outcome between Asian group (n=508) and Western group (n=472). Bleeding events were defined according to the VARC-3 criteria, and type 2 or higher was classified as major bleeding. The composite outcome of thromboembolic and bleeding events included major bleeding (type 2 or higher) and thromboembolic events.
Results: Before matching, significant differences were observed in baseline characteristics such as age, hypertension and overweight and atrial fibrillation between Asian and Western groups. Overall, the Aian population demonstrated significantly better long-term survival, and lower incidences of thromboembolic events, any bleeding and the composite outcome of bleeding and thromboembolic events. After matching, 141 well-balanced pairs were obtained. In the matched cohort, overall survival remained significantly better in the Asian group (P < 0.001). While there was no significant difference in any bleeding events between the groups (P = 0.231), major bleeding occurred significantly more frequently in the Western group (P = 0.028). Thromboembolic events and the composite outcome of major bleeding and thromboembolic events were also significantly more frequent in the Western group (P = 0.002 and P = 0.013, respectively).

Conclusions: After mechanical MVR, Asian patients demonstrated superior long-term survival and a lower incidence of anticoagulation-related complications, including bleeding and thromboembolic events, compared with Western patients. These findings suggest that population-based differences should be considered when determining prosthetic valve type, and highlight the need for further research to define optimal anticoagulation targets tailored to Asian populations.

Authors
Jae Woong Choi (1), Yoonjin Kang (1), Suk Ho Sohn (1), Ho Young Hwang (1), Kyung Hwan Kim (1), Jeffrey Gaca (2), Brittany Zwischenberger (2), Carmelo Milano (2), Keith Carr (2), Donald Glower (2)
Institutions
(1) Seoul National University Hospital, Seoul, South Korea, (2) Duke University Medical Center, Durham, NC

Presentation Duration

There is no formal presentation for posters. Your poster will be on display on your assigned day from 9:00AM - 4:00PM 

View Submission


ADULT CARDIAC

Mitral and Tricuspid Valve